Global Blood secures FDA approval for new pill to treat sickle cell disease

Global Blood secures FDA approval for new pill to treat sickle cell disease

By ADAM FEUERSTEIN

JANICE HANEY CARR/CDC/SICKLE CELL FOUNDATION OF GEORGIA VIA AP

The novel drug was developed by the biotech firm Global Blood Therapeutics and will be sold under the brand name Oxbryta.

READ MORE